3 Drug Catalysts to Watch in 2013
Motley Fool
Merck Pharmaceuticals' Suvorexant: A Wake-Up Call
Seeking Alpha
Promising insomnia pill from Merck remains 'critical' to future amid recent setbacks
Newark Star-Ledger, NJ
This Drug Helps Investors Rest Easy
Motley Fool
FDA reviewing Merck's experimental insomnia drug
Boston.com, MA
Merck Poised To Soar On New Insomnia Drug
Seeking Alpha
New Data on Merck's Insomnia Drug
Yahoo/Zacks
Merck's insomnia drug shows positive results
Marketwatch
Merck's Next-Gen Sleep Disorder Drug - A Blockbuster?
Seeking Alpha